Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001181431-13-007974

Options or other derivatives

  • Chief Scientific Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Doberstein Stephen K · Chief Scientific Officer

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-02-06 Grant or award : show line 1 in the form Stock Option +50,000 $8.80 2021-02-05 50,000 50,000 D
2013-02-06 Grant or award : show line 2 in the form Stock Option +50,000 $8.80 2021-02-05 50,000 50,000 D
Loading xslF345X03/rrd369528.xml…